Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Walter H Curioso1, Magaly M Blas2, Ann E Kurth3

  • 1Universidad Peruana Cayetano Heredia. Lima, Perú ; University of Washington. Seattle, Washington, USA ; Médico, Maestro en Salud Pública ; Especialista en Informática Biomédica.

Revista Peruana De Medicina Experimental Y Salud Publica
|September 5, 2015
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya.

The International journal on drug policy·2025
Same author

Polysubstance Use and Related Risk Behaviors among People Who Inject Drugs in Kenya Preparing for Hepatitis C Virus Treatment.

Viruses·2024
Same author

Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya.

The International journal on drug policy·2023
Same author

Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings: focus group discussions with healthcare providers in Kenya.

Global public health·2022
Same author

HCV genotype 4 subtypes in people who inject drugs in sub-Saharan Africa.

The lancet. Gastroenterology & hepatology·2022
Same author

Hepatitis C treatment outcomes among people who inject drugs accessing harm reduction settings in Kenya.

Journal of viral hepatitis·2022

Innovative technologies show promise for preventing and controlling HIV and sexually transmitted infections (STIs). Further research is needed to fully understand their impact on disease incidence and economic evaluations.

Area of Science:

  • Public Health
  • Infectious Disease Control
  • Health Informatics

Background:

  • Information and communication technologies (ICT) are increasingly utilized globally for HIV/STI prevention.
  • Existing evidence on the effectiveness of ICT for HIV/STI control is limited but compelling.
  • The potential applications of ICT in this field are vast, though many are still in early stages.

Purpose of the Study:

  • To review the published literature on the use of ICT applications in HIV/STI control.
  • To assess the current evidence base for ICT interventions in HIV/STI prevention and management.
  • To identify areas where further research and rigorous study designs are needed.

Main Methods:

  • Systematic review of published literature on ICT applications for HIV/STI control.

Related Experiment Videos

  • Analysis of studies examining the use of various technologies (Internet, mobile devices, etc.).
  • Evaluation of evidence regarding effectiveness, implementation, and impact.

    • Main Results:

    • ICT tools can enhance HIV/STI screening, prevention, surveillance, and patient care.
    • Evidence for the impact on disease incidence and economic evaluations remains limited.
    • Rigorous study designs are crucial for evaluating the effectiveness of these technologies.

    Conclusions:

    • Appropriately utilized ICT holds significant potential to improve HIV/STI control efforts.
    • Further research is essential to establish best practices and measure the full impact of ICT.
    • ICT can be beneficial in both resource-constrained and resource-rich settings for HIV/STI management.